Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Nuki

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Current Opinion in Rheumatology|February 5, 2014
An appraisal of the 2012 American College of Rheumatology Guidelines for the Management of GoutGeorge Nuki
Current Rheumatology Reports|July 22, 2008
Colchicine: its mechanism of action and efficacy in crystal-induced inflammationGeorge Nuki
Rheumatic Diseases Clinics of North America|May 24, 2006
Treatment of crystal arthropathy--history and advancesGeorge Nuki
The Journal of the Royal College of Physicians of Edinburgh|June 23, 2020
Changing paradigms in the management of goutGeorge Nuki, Philip Riches
Arthritis Research & Therapy|July 6, 2006
A concise history of gout and hyperuricemia and their treatmentGeorge Nuki, Peter A Simkin
Polish Archives of Internal Medicine|April 22, 2017
Current management of gout: practical messages from 2016 EULAR guidelinesGeorge Nuki, Michael Doherty, Pascal Richette
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2005
Association of low general health status, measured prospectively by Euroqol EQ5D, with osteoporosis, independent of a history of prior fractureVeena Dhillon, Nigel Hurst, Jim Hannan, et al.
Arthritis and Rheumatism|November 13, 2002
Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trialGeorge Nuki, Barry Bresnihan, Moraye B Bear, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 31, 2013
Cost-effectiveness of febuxostat in chronic goutStephen M Beard, Birgitta G von Scheele, George Nuki, et al.
Nature Reviews. Rheumatology|April 7, 2019
Spontaneous dog osteoarthritis - a One Medicine visionRichard L Meeson, Rory J Todhunter, Gordon Blunn, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Opinion in Rheumatology|February 5, 2014
An appraisal of the 2012 American College of Rheumatology Guidelines for the Management of GoutGeorge Nuki
Current Rheumatology Reports|July 22, 2008
Colchicine: its mechanism of action and efficacy in crystal-induced inflammationGeorge Nuki
Rheumatic Diseases Clinics of North America|May 24, 2006
Treatment of crystal arthropathy--history and advancesGeorge Nuki
The Journal of the Royal College of Physicians of Edinburgh|June 23, 2020
Changing paradigms in the management of goutGeorge Nuki, Philip Riches
Arthritis Research & Therapy|July 6, 2006
A concise history of gout and hyperuricemia and their treatmentGeorge Nuki, Peter A Simkin
Polish Archives of Internal Medicine|April 22, 2017
Current management of gout: practical messages from 2016 EULAR guidelinesGeorge Nuki, Michael Doherty, Pascal Richette
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 6, 2005
Association of low general health status, measured prospectively by Euroqol EQ5D, with osteoporosis, independent of a history of prior fractureVeena Dhillon, Nigel Hurst, Jim Hannan, et al.
Arthritis and Rheumatism|November 13, 2002
Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trialGeorge Nuki, Barry Bresnihan, Moraye B Bear, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 31, 2013
Cost-effectiveness of febuxostat in chronic goutStephen M Beard, Birgitta G von Scheele, George Nuki, et al.
Nature Reviews. Rheumatology|April 7, 2019
Spontaneous dog osteoarthritis - a One Medicine visionRichard L Meeson, Rory J Todhunter, Gordon Blunn, et al.
Pageof 3